AGL 38.55 Decreased By ▼ -0.01 (-0.03%)
AIRLINK 200.83 Decreased By ▼ -6.94 (-3.34%)
BOP 10.19 Increased By ▲ 0.13 (1.29%)
CNERGY 6.57 Decreased By ▼ -0.51 (-7.2%)
DCL 9.68 Decreased By ▼ -0.31 (-3.1%)
DFML 39.90 Decreased By ▼ -1.24 (-3.01%)
DGKC 97.67 Decreased By ▼ -5.79 (-5.6%)
FCCL 35.10 Decreased By ▼ -1.25 (-3.44%)
FFBL 86.00 Decreased By ▼ -5.59 (-6.1%)
FFL 13.95 Decreased By ▼ -0.65 (-4.45%)
HUBC 130.45 Decreased By ▼ -8.98 (-6.44%)
HUMNL 14.00 Decreased By ▼ -0.10 (-0.71%)
KEL 5.64 Decreased By ▼ -0.33 (-5.53%)
KOSM 7.30 Decreased By ▼ -0.56 (-7.12%)
MLCF 45.60 Decreased By ▼ -1.68 (-3.55%)
NBP 66.38 Decreased By ▼ -7.38 (-10.01%)
OGDC 221.50 Decreased By ▼ -1.16 (-0.52%)
PAEL 38.45 Increased By ▲ 0.34 (0.89%)
PIBTL 8.96 Decreased By ▼ -0.31 (-3.34%)
PPL 196.85 Decreased By ▼ -9.00 (-4.37%)
PRL 38.85 Decreased By ▼ -1.00 (-2.51%)
PTC 25.60 Decreased By ▼ -1.02 (-3.83%)
SEARL 104.50 Decreased By ▼ -5.74 (-5.21%)
TELE 9.06 Decreased By ▼ -0.17 (-1.84%)
TOMCL 36.41 Decreased By ▼ -1.80 (-4.71%)
TPLP 13.64 Decreased By ▼ -0.13 (-0.94%)
TREET 25.20 Decreased By ▼ -1.25 (-4.73%)
TRG 58.10 Decreased By ▼ -2.44 (-4.03%)
UNITY 33.55 Decreased By ▼ -0.59 (-1.73%)
WTL 1.73 Decreased By ▼ -0.15 (-7.98%)
BR100 11,896 Decreased By -402.5 (-3.27%)
BR30 37,383 Decreased By -1494.9 (-3.85%)
KSE100 111,070 Decreased By -3790.4 (-3.3%)
KSE30 34,909 Decreased By -1287 (-3.56%)
World

Australia reports first death from blood clots 'likely' linked to AstraZeneca vaccine

  • "In the absence of an alternative cause for the clinical syndrome, VSIG believed that a causative link to vaccination should be assumed at this time," the TGA said.
  • The TGA said her case had been complicated by underlying medical conditions, including diabetes, "as well as some atypical features."
Published April 16, 2021

SYDNEY: Australia on Friday reported its first death from blood clots linked to the AstraZeneca COVID-19 vaccine after the country's regulator said a 48-year-old woman's fatality was "likely" linked to the shot.

Australia's Vaccine Safety Investigation Group (VSIG), which held a late meetig on Friday, concluded the New South Wales woman's death was likely linked to the vaccination, the Therapeutic Goods Administration said in a statement.

"In the absence of an alternative cause for the clinical syndrome, VSIG believed that a causative link to vaccination should be assumed at this time," the TGA said.

This was the third instance of the rare blood clots linked to the vaccine in Australia with the other two patients recovering well, the TGA added.

The 48-year-old woman died four days after receiving the vaccination.

The TGA said her case had been complicated by underlying medical conditions, including diabetes, "as well as some atypical features."

Comments

Comments are closed.